| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918312 | Radiotherapy and Oncology | 2014 | 4 Pages |
Abstract
If post-implant dosimetry is generally within the optimal range, distant rather than local failure appears to be the main cause of BF. Hormone treatment is therefore the most commonly indicated secondary treatment intervention (STI). Delaying the start of STI prevents the unnecessary treatment of men who undergo PSA 'bounce' and have PSA dynamics initially mimicking those of BF.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
David S. Lamb, Lynne Greig, Grant L. Russell, John N. Nacey, Kim Broome, Rod Studd, Brett Delahunt, Douglas Iupati, Mohua Jain, Colin Rooney, Judy Murray, Peter J. Lamb, Peter B. Bethwaite,